Table 3.
Proportions of patients within each primary care providers (PCP) with guideline adherence and potential misuse outcomes.
| PCP adherence proportions* | Total (N = 67) mean % ± SD (range) | Site 1 (n = 10) mean % ± SD (range) | Site 2 (n = 12) mean % ± SD (range) | Site 3 (n = 45) mean % ± SD (range) | P† |
|---|---|---|---|---|---|
| Opioid treatment agreement‡ | 48 ± 26 (0–100) | 59 ± 25 (20–83) | 51 ± 23 (0–75) | 45 ± 27 (0–100) | 0.30 |
| Urine drug screen§ | 56 ± 29 (0–100) | 31 ± 27 (4–92) | 35 ± 27 (0–71) | 67 ± 23 (0–100) | <0.0001 |
| Early refills|| | 36 ± 20 (0–75) | 41 ± 16 (10–67) | 25 ± 23 (0–57) | 38 ± 19 (5–75) | 0.09 |
*
Proportion of each individual PCP’s patients with each outcome.
†
χ2 test for categorical variables and analysis of variance for continuous variables across 3 sites.
‡
Electronic health record documentation of an opioid treatment agreement ever.
§
Urine drug screen in the past 12 mo.
||
An opioid prescription written 7 to 25 d after the previous prescription for the same medication.